EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International Survey

Jalpa Devi, Colleen Y Colbert, Sophia Haroon Dar, Beatriz Gros, Ashkan Rezazadeh Ardabili, Agnes H Y Ho, Anita D Misra-Hebert, Joseph Sleiman

Digestive Diseases and Sciences · 2026

DOI: 10.1007/s10620-026-09987-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Jalpa Devi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Artificial Intelligence, Attitude of Health Personnel, Health Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Artificial intelligence (AI) is transforming inflammatory bowel disease (IBD) care, but concerns over data quality, privacy, and provider familiarity remain. AIMS: To examine international health care providers' (HCPs) perceptions, clinical use of, and barriers to applying AI in IBD care. METHODS: An anonymous 17-item survey was developed and pretested by an international team. The survey was fielded internationally from January to May 2025 via social media, international IBD newsletters and email listservs. RESULTS: Of 323 IBD professionals from North America (35.3%), Europe (26.0%), Asia-Pacific (19.2%), 207 (64.1%) viewed AI as very or extremely promising. AI-assisted endoscopy was reportedly adopted by 131 (40.6%) of respondents, but only 69 (21.4%) reported applying AI in IBD care or research. Males supported AI in IBD endoscopic scoring (89.9% vs. 79.1%, p = 0.009) and radiomics more than females (86.6% vs. 75.2%, p = 0.022), while females endorsed AI for patient education more than males (81.5% vs. 70.6%, p = 0.026). 145 (44.9%) respondents were concerned about AI usage in IBD care. Females were less concerned about cost (18.5% vs. 30.1%, p = 0.019) and more concerned about oversight (28.7% vs. 14.7%, p = 0.003). Concerns regarding AI usage decreased with age (OR 0.021 for age > 55 compared to age 25-34 years old; 95% CI 0.13-0.84). Exposure to IBD-focused AI-based tools was associated with more favorable perceptions of AI use in IBD care (OR 2.63, 95% CI 1.25-5.53). CONCLUSION: Based upon survey results, HCPs had concerns over insufficient education, regulatory ambiguity, and perplexing implementation strategies for AI. Proven clinical benefit (74.9%) and adequate AI training (72.1%) are the top solutions for enabling the appropriate adoption of AI tools in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesArtificial IntelligenceAttitude of Health PersonnelHealth PersonnelHumansFemaleMaleAdultMiddle AgedSurveys and Questionnaires

Stichwörter der Autor:innen

AI implementationArtificial intelligenceEndoscopyHealth personnelIBDInflammatory bowel diseases

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Cleveland Clinic Education Foundation, Cleveland Clinic, Cleveland, OH, USA.
  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Division of Gastroenterology, Southern Illinois University School of Medicine, Springfield, IL, USA.
  • Reina Sofia University Hospital, IMIBIC, University of Cordoba, Cordoba, Spain.
  • Centro de Investigación Biomedica en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.

Zitieren

APA

Devi, J., Colbert, C. Y., Dar, S. H., Gros, B., Ardabili, A. R., Ho, A. H. Y., Misra-Hebert, A. D., & Sleiman, J. (2026). Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International Survey. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-09987-3

Vancouver

Devi J, Colbert CY, Dar SH, Gros B, Ardabili AR, Ho AHY, et al. Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International Survey. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-09987-3

BibTeX
@article{Devi2026,
  author = {Devi, Jalpa and Colbert, Colleen Y and Dar, Sophia Haroon and Gros, Beatriz and Ardabili, Ashkan Rezazadeh and Ho, Agnes H Y and Misra-Hebert, Anita D and Sleiman, Joseph},
  title = {Healthcare Providers' Perspectives on the Role of Artificial Intelligence in the Care of Patients with Inflammatory Bowel Disease: An International Survey},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  doi = {10.1007/s10620-026-09987-3}
}
Kostenlos starten →